Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed)
This grant supports early-stage research for developing new drugs to treat specific fungal infections caused by Candida auris, Aspergillus fumigatus, Coccidioides, and Mucorales. It uses a two-phase award system where progression to the second phase depends on achieving certain goals in the first phase.
The purpose of this notice of funding opportunity (NOFO) is to support milestone-driven, early-stage translational research focused on drug discovery and development of novel therapeutics against select fungal pathogens including: Candida species, specifically Candida auris; Aspergillus fumigatu…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers